Company press releases

Displaying 1 - 50 of 67 results
Released Company Title Industry Topic
15 Jul 2026
08:00 CEST 		ABL Diagnostics ABL Diagnostics informée du franchissement à la baisse du seuil de 95 % par son actionnaire de référence ABL 20103010 Biotechnology Legal
15 Jul 2026
08:00 CEST 		ABL Diagnostics ABL Diagnostics Informed that its Reference Shareholder ABL Has Crossed Below the 95% Threshold 20103010 Biotechnology Legal
13 Jul 2026
08:00 CEST 		ABL Diagnostics ABL DIAGNOSTICS : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ S1 2026 20103010 Biotechnology Legal
10 Jul 2026
08:00 CEST 		ABL Diagnostics ABL Diagnostics : Cession d'un nouveau bloc d'actions par son actionnaire principal ABL 20103010 Biotechnology Share history
10 Jul 2026
08:00 CEST 		ABL Diagnostics ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL 20103010 Biotechnology Share history
02 Jul 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics - Approbation du versement de dividendes au titre de l’exercice 2025 20103010 Biotechnology Dividend
02 Jul 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics – Approval of Dividend Distribution for Fiscal Year 2025 20103010 Biotechnology Dividend
18 Jun 2026
13:51 CEST 		ABL Diagnostics ABL Diagnostics : trajectoire de croissance confirmée et fort levier de revalorisation identifié 20103010 Biotechnology Trends / Analyses
18 Jun 2026
13:51 CEST 		ABL Diagnostics ABL Diagnostics: Growth Trajectory Confirmed and Strong Upside Potential Identified 20103010 Biotechnology Trends / Analyses
12 Jun 2026
08:00 CEST 		ABL Diagnostics ABL Diagnostics et CDL Pharma remportent un contrat international pluriannuel pouvant atteindre 2,7 M€ jusqu’en 2031 20103010 Biotechnology News contracts
12 Jun 2026
08:00 CEST 		ABL Diagnostics ABL Diagnostics and CDL Pharma Secure a Multi-year International Contract of up to €2.7 Million Through 2031 20103010 Biotechnology News contracts
10 Jun 2026
08:00 CEST 		ABL Diagnostics ABL Diagnostics (ABLD) Announces the Submission of a Takeover Bid for Texcell France 20103010 Biotechnology Takeover bids
10 Jun 2026
08:00 CEST 		ABL Diagnostics ABL Diagnostics (ABLD) annonce le dépôt d’une offre de reprise de Texcell France 20103010 Biotechnology Takeover bids
10 Jun 2026
00:00 CEST 		ABL Diagnostics ABL Diagnostics: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL 20103010 Biotechnology General meeting / Board Meeting
10 Jun 2026
00:00 CEST 		ABL Diagnostics ABL Diagnostics: Information Relating to the Total Number of Voting Rights and the Total Number of Shares Composing the Share Capital 20103010 Biotechnology General meeting / Board Meeting
09 Jun 2026
19:00 CEST 		ABL Diagnostics ABL Diagnostics: Ordinary and Extraordinary General Meeting of June 30, 2026 – Terms for Making Available or Consulting Preparatory Documents 20103010 Biotechnology General meeting / Board Meeting
09 Jun 2026
19:00 CEST 		ABL Diagnostics ABL Diagnostics : Assemblée Générale Ordinaire et Extraordinaire du 30 juin 2026 – Modalités de mise à disposition ou de consultation des documents préparatoires 20103010 Biotechnology General meeting / Board Meeting
05 Jun 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics: Sale of a new block of shares by its main shareholder ABL 20103010 Biotechnology Share history
05 Jun 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics : Cession d'un nouveau bloc d'actions par son actionnaire principal ABL 20103010 Biotechnology Share history
04 Jun 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics : Cession d'un nouveau bloc d'actions par son actionnaire principal ABL 20103010 Biotechnology Share history
04 Jun 2026
18:00 CEST 		ABL Diagnostics ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL 20103010 Biotechnology Share history
01 Jun 2026
18:06 CEST 		ABL Diagnostics ABL Diagnostics Presents Its Financial Roadmap and Growth Outlook for 2026 20103010 Biotechnology Legal
01 Jun 2026
18:06 CEST 		ABL Diagnostics ABL DIAGNOSTICS PRÉSENTE SA FEUILLE DE ROUTE FINANCIÈRE ET SES PERSPECTIVES DE CROISSANCE POUR 2026 20103010 Biotechnology Legal
19 May 2026
18:00 CEST 		ABL Diagnostics ALLINVEST RÉITÈRE SON OPINION « ACHAT » SUR ABL DIAGNOSTICS ET MAINTIENT UN OBJECTIF DE COURS DE 8,4 € (MATÉRIALISANT UN MULTIPLE DE X2,2) 20103010 Biotechnology Trends / Analyses
19 May 2026
18:00 CEST 		ABL Diagnostics Allinvest Reiterates Its "BUY" Rating on ABL Diagnostics and Maintains a €8.4 Target Price (Representing a 2.2X Multiple) 20103010 Biotechnology Trends / Analyses
18 May 2026
08:00 CEST 		ABL Diagnostics ABL Diagnostics propose une augmentation significative de son dividende au titre de l’exercice 2025 20103010 Biotechnology Dividend
18 May 2026
08:00 CEST 		ABL Diagnostics ABL Diagnostics Proposes a Significant Increase in Its Dividend for FY2025 20103010 Biotechnology Dividend
11 May 2026
08:00 CEST 		ABL Diagnostics ABL DIAGNOSTICS PUBLIE DES RÉSULTATS ANNUELS 2025 HISTORIQUES : EXPLOSION DU RÉSULTAT NET (+246%), FORTE RENTABILITÉ OPÉRATIONNELLE ET ACCÉLÉRATION MONDIALE 20103010 Biotechnology Commercial results
11 May 2026
08:00 CEST 		ABL Diagnostics ABL Diagnostics Reports Historic 2025 Annual Results: Net Income Explosion (+246%), Strong Operating Profitability and Global Acceleration 20103010 Biotechnology Commercial results
08 May 2026
00:01 CEST 		ABL Diagnostics ABL Diagnostics: Availability of the 2025 Annual Financial Report 20103010 Biotechnology Legal
08 May 2026
00:01 CEST 		ABL Diagnostics ABL DIAGNOSTICS : MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025 20103010 Biotechnology Legal
17 Mar 2026
18:00 CET 		ABL Diagnostics ABL Diagnostics : Cession d'un nouveau bloc d'actions par son actionnaire principal ABL 20103010 Biotechnology Other financial transaction
17 Mar 2026
18:00 CET 		ABL Diagnostics ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL 20103010 Biotechnology Other financial transaction
19 Feb 2026
08:00 CET 		ABL Diagnostics ABL Diagnostics Update Regarding Non-Binding Letter of Intent 20103010 Biotechnology Mergers, Acquisitions, Transfers
19 Feb 2026
08:00 CET 		ABL Diagnostics Mise à jour d’ABL Diagnostics concernant la lettre d’intention non contraignante 20103010 Biotechnology Mergers, Acquisitions, Transfers
13 Feb 2026
18:00 CET 		ABL Diagnostics ABL SA Executes the First Purchase Notice of ABL Diagnostics Shares With Alumni Capital 20103010 Biotechnology Other financial transaction
13 Feb 2026
18:00 CET 		ABL Diagnostics ABL SA exécute un premier Avis d’Achat portant sur des actions ABL Diagnostics avec Alumni Capital 20103010 Biotechnology Other financial transaction
03 Feb 2026
18:00 CET 		ABL Diagnostics ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL 20103010 Biotechnology Other financial transaction
03 Feb 2026
18:00 CET 		ABL Diagnostics ABL Diagnostics : Cession d'un nouveau bloc d'actions par son actionnaire principal ABL 20103010 Biotechnology Other financial transaction
06 Jan 2026
18:00 CET 		ABL Diagnostics ABL DIAGNOSTICS : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ S2 2025 20103010 Biotechnology Share history
19 Dec 2025
08:00 CET 		ABL Diagnostics ABL Diagnostics Informs the Market of a Non‑Binding Letter of Intent Between ABL S.A. and ProPhase Labs (Nasdaq: PRPH) for a Proposed Reverse Merger 20103010 Biotechnology Other financial transaction
19 Dec 2025
08:00 CET 		ABL Diagnostics ABL Diagnostics informe le marché de la signature d’une lettre d’intention non contraignante entre ABL S.A. et ProPhase Labs (Nasdaq : PRPH) en vue d’un projet de reverse merger 20103010 Biotechnology Other financial transaction
05 Dec 2025
17:00 CET 		ABL Diagnostics Information on a Temporary Transfer of ABL Diagnostics Shares 20103010 Biotechnology Other financial transaction
05 Dec 2025
17:00 CET 		ABL Diagnostics  Information sur une cession temporaire d’actions ABL Diagnostics 20103010 Biotechnology Other financial transaction
14 Nov 2025
08:00 CET 		ABL Diagnostics ABL Diagnostics Appoints Eurobio Scientific as Exclusive Distributor for Its VELA Product Line in a Targeted Segment of the French Market 20103010 Biotechnology Alliances and agreements
14 Nov 2025
08:00 CET 		ABL Diagnostics ABL Diagnostics confie à Eurobio Scientific la distribution exclusive de sa gamme VELA sur un périmètre ciblé en France 20103010 Biotechnology Alliances and agreements
22 Oct 2025
18:00 CEST 		ABL Diagnostics ABL Diagnostics – Annonce d’un second accord entre ABL SA et Alumni Capital 20103010 Biotechnology Other subject
22 Oct 2025
18:00 CEST 		ABL Diagnostics ABL Diagnostics – Announcement of a Second Agreement Between ABL SA and Alumni Capital 20103010 Biotechnology Other subject
16 Oct 2025
18:00 CEST 		ABL Diagnostics ABL Diagnostics: Switch to Continuous Trading on Euronext Paris as From November 3rd, 2025 20103010 Biotechnology Other subject
16 Oct 2025
18:00 CEST 		ABL Diagnostics ABL Diagnostics : Passage en cotation continue sur Euronext Paris à compter du 3 novembre 2025 20103010 Biotechnology Other subject